Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm

<p>Is your patient's proteinuria low enough? New KDIGO goals: target the immune cause and hit < 0.5 g/day to preserve kidney function.<br />  <br /> Credit available for this activity expires: 12/2/2026<br /> Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/viewarticle/1003055?ecd=bdc_podcast_libsyn_mscpedu" target="_blank" rel= "noopener">https://www.medscape.org/viewarticle/1003055?ecd=bdc_podcast_libsyn_mscpedu</a></p>